Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02767492 · ClinicalTrials.gov registry record · NA
Steroid Injection vs. BioDRestore for Patients With Knee OA
A NA study, sponsored by The Hawkins Foundation.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02767492 is a NA study that has completed, run by The Hawkins Foundation. The registered enrollment target is 90 participants.
The verdict
NCT02767492, a NA study, has completed, sponsored by The Hawkins Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study will include patients who are diagnosed with knee OA and are recommended for a knee injection. Study subjects will be randomized to receive either the standard of care knee injection (steroid) or amniotic tissue injection (BioDRestore). Study subjects will be asked for permission for a baseline knee aspiration prior to the knee injection. At 6 months post-injection, knee aspirations will be taken and sent for analysis. Study subjects will be followed for 1 year post-injection to include range of motion measurements and patient-reported pain/functional outcome measurements. X-rays will also be taken at the 1-year post-injection appointment.
Interventions
- DRUG Kenalog
- DEVICE BioD Restore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02767492
The ClinicalTrials.gov registry entry for NCT02767492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Hawkins Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Kenalog is the first listed.
NCT02767492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02767492 about?
NCT02767492 is a clinical study titled "Steroid Injection vs. BioDRestore for Patients With Knee OA". This study will include patients who are diagnosed with knee OA and are recommended for a knee injection. Study subjects will be randomized to receive either the standard of care knee injection (steroid) or amniotic tissue injection (BioDRestore). Study subjects will be asked for permission for a ba...
What is the current status of trial NCT02767492?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2017-01. Estimated completion is 2020-01.
What interventions are being tested in trial NCT02767492?
The interventions under investigation include: Kenalog (DRUG), BioD Restore (DEVICE).
Who is sponsoring clinical trial NCT02767492?
This trial is sponsored by The Hawkins Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.